63 related articles for article (PubMed ID: 2805783)
1. Southern blot analysis of transformed growth factor alpha and beta DNA in normal kidney and in renal cell carcinoma.
Wade TP; Comelia LG; Sargent ER; Anglard P; Kasid A; Linehan WM
Curr Surg; 1989; 46(5):401-3. PubMed ID: 2805783
[No Abstract] [Full Text] [Related]
2. Expression of transforming growth factor alpha in normal human adult kidney and enhanced expression of transforming growth factors alpha and beta 1 in renal cell carcinoma.
Gomella LG; Sargent ER; Wade TP; Anglard P; Linehan WM; Kasid A
Cancer Res; 1989 Dec; 49(24 Pt 1):6972-5. PubMed ID: 2582439
[TBL] [Abstract][Full Text] [Related]
3. 1,25-Dihydroxyvitamin D3 receptor measurement in primary renal cell carcinomas and autologous normal kidney tissue.
Trydal T; Bakke A; Aksnes L; Aarskog D
Cancer Res; 1988 May; 48(9):2458-61. PubMed ID: 2833346
[TBL] [Abstract][Full Text] [Related]
4. [Fluorocytophotometic DNA studies in kidney carcinoma].
Vogel J; Schmitz C; Födisch HJ; Jaeger N; Molitor D
Verh Dtsch Ges Pathol; 1989; 73():405-8. PubMed ID: 2482627
[TBL] [Abstract][Full Text] [Related]
5. High levels of S-100a0 (alpha alpha) protein in tumor tissues and in sera of patients with renal cell carcinoma.
Kato K; Haimoto H; Ariyoshi Y; Horisawa M; Washida H; Kimura S
Jpn J Cancer Res; 1985 Sep; 76(9):856-62. PubMed ID: 3932285
[TBL] [Abstract][Full Text] [Related]
6. [Hormone receptors in human renal cell carcinomas?].
Krech RH; Grote M; Vollmer G; Gerdes J; Löhrs U
Verh Dtsch Ges Pathol; 1988; 72():241-4. PubMed ID: 3218339
[No Abstract] [Full Text] [Related]
7. Renal cell carcinoma. An immunohistochemical study. Preliminary report on 20 cases.
Luciani L; Scappini P; Leonardi E; Pusiol T; Piscioli F
Acta Urol Belg; 1986; 54(3):256-64. PubMed ID: 3535448
[No Abstract] [Full Text] [Related]
8. Cytokine production in primary histoculture by human normal kidney, renal cell carcinoma and benign renal angiomyolipoma tissues.
Chang SG; Shin C; Rho SK; Kim DK; Kim JH
Anticancer Res; 1998; 18(6A):4195-200. PubMed ID: 9891467
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the paracrine and endocrine effects of genitourinary tumor produced growth factors.
Linehan WM; Robertson CN; Miller ET; Santora AC
Prog Clin Biol Res; 1988; 277():135-43. PubMed ID: 3054908
[No Abstract] [Full Text] [Related]
10. Visualisation of transforming growth factor-beta 1, tissue kallikrein, and kinin and transforming growth factor-beta receptors on human clear-cell renal carcinoma cells.
Moodley R; Snyman C; Odhav B; Bhoola KD
Biol Chem; 2005 Apr; 386(4):375-82. PubMed ID: 15899700
[TBL] [Abstract][Full Text] [Related]
11. [Steroid receptors in human renal adenocarcinoma: preliminary experience].
Muzzonigro G; Dellabella M; Beatrici V; Rosciani C; Bartolucci MA; Possati L; Polito M
Boll Soc Ital Biol Sper; 1988 Jun; 64(6):547-53. PubMed ID: 3190907
[No Abstract] [Full Text] [Related]
12. Serum transforming growth factor-beta1 in patients with renal cell carcinoma.
Wunderlich H; Steiner T; Junker U; Knöfel B; Schlichter A; Schubert J
J Urol; 1997 May; 157(5):1602-3. PubMed ID: 9112485
[TBL] [Abstract][Full Text] [Related]
13. Purification and biological properties of type beta transforming growth factor from mouse transformed cells.
Fernandez-Pol JA; Klos DJ; Grant GA
Cancer Res; 1986 Oct; 46(10):5153-61. PubMed ID: 3489522
[TBL] [Abstract][Full Text] [Related]
14. [Histospectrophotometric characteristics of renal cell cancer (based on the data on DNA content)].
Loginov VA
Arkh Patol; 1986; 48(7):24-30. PubMed ID: 3753247
[TBL] [Abstract][Full Text] [Related]
15. Altered expression of transforming growth factor-alpha: an early event in renal cell carcinoma development.
Everitt JI; Walker CL; Goldsworthy TW; Wolf DC
Mol Carcinog; 1997 Jul; 19(3):213-9. PubMed ID: 9254888
[TBL] [Abstract][Full Text] [Related]
16. Functional intactness of stimulatory and inhibitory autocrine loops in human renal carcinoma cell lines of the clear cell type.
Ramp U; Jaquet K; Reinecke P; Schardt C; Friebe U; Nitsch T; Marx N; Gabbert HE; Gerharz CD
J Urol; 1997 Jun; 157(6):2345-50. PubMed ID: 9146668
[TBL] [Abstract][Full Text] [Related]
17. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
[TBL] [Abstract][Full Text] [Related]
18. Expression of retinoic acid receptor beta in human renal cell carcinomas correlates with sensitivity to the antiproliferative effects of 13-cis-retinoic acid.
Hoffman AD; Engelstein D; Bogenrieder T; Papandreou CN; Steckelman E; Dave A; Motzer RJ; Dmitrovsky E; Albino AP; Nanus DM
Clin Cancer Res; 1996 Jun; 2(6):1077-82. PubMed ID: 9816270
[TBL] [Abstract][Full Text] [Related]
19. Loss of function of the tissue specific transcription factor HNF1 alpha in renal cell carcinoma and clinical prognosis.
Anastasiadis AG; Lemm I; Radzewitz A; Lingott A; Ebert T; Ackermann R; Ryffel GU; Schulz WA
Anticancer Res; 1999; 19(3A):2105-10. PubMed ID: 10470156
[TBL] [Abstract][Full Text] [Related]
20. Renal oncocytoma. I. Cytochrome c oxidase in normal and neoplastic renal tissue as detected by immunohistochemistry--a valuable aid to distinguish oncocytomas from renal cell carcinomas.
Ortmann M; Vierbuchen M; Koller G; Fischer R
Virchows Arch B Cell Pathol Incl Mol Pathol; 1988; 56(3):165-73. PubMed ID: 2906189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
